LIVER RESECTION VERSUS RADIOFREQUENCY ABLATION FOR EARLY-STAGE HEPATOCELLULAR CARCINOMA: AN EVIDENCE-BASED NARRATIVE REVIEW OF ONCOLOGICAL OUTCOMES AND TREATMENT SELECTION
Authors:
- Gabriela KrygerGKGabriela Kryger
- Paweł Jan BabińskiPBPaweł Jan Babiński
- Magdalena WiśniewskaMWMagdalena Wiśniewska
- Zuzanna Karolina JęDrzejczakZJZuzanna Karolina JęDrzejczak
- Andrzej Józef HorabikAHAndrzej Józef Horabik
- Małgorzata DmochowskaMDMałgorzata Dmochowska
- Julia HertmanowskaJHJulia Hertmanowska
- Marta PiotrowskaMPMarta Piotrowska
- Krzysztof ChmuraKCKrzysztof Chmura
- Adrianna Alicja PiekarskaAPAdrianna Alicja Piekarska
Open Access
- 6 January 2026
- journal article
- review article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- No. 1(49)
Abstract
Background: Surgical resection (LR) and radiofrequency ablation (RFA) are established curative options for early-stage hepatocellular carcinoma (HCC), yet their relative benefits remain debated, particularly regarding long-term survival, recurrence control, and patient selection. Objectives: To synthesize contemporary evidence comparing liver resection and radiofrequency ablation for early-stage HCC, with a focus on oncological outcomes, recurrence patterns, perioperative safety, and clinically relevant subgroups. Methods: An evidence-based narrative review was conducted using structured searches of PubMed/MEDLINE and the Cochrane Library. Systematic reviews, meta-analyses, randomized controlled trials, and high-quality observational studies comparing LR and RFA in early-stage HCC were included. Outcomes of interest comprised overall survival (OS), recurrence-free or disease-free survival (RFS/DFS), tumor recurrence, perioperative morbidity, and cost-effectiveness. Findings were synthesized qualitatively. Results: Randomized controlled trials consistently demonstrated no statistically significant difference in overall survival between LR and RFA. In contrast, meta-analyses and propensity-adjusted observational studies suggested improved long-term survival following resection in selected patients with preserved liver function. Across comparative studies, recurrence-free survival and local tumor control consistently favored resection. Subgroup analyses indicated comparable survival outcomes between modalities in patients with very small tumors, impaired hepatic reserve (Child–Pugh class B), and elderly populations, while tumor size and anatomical location emerged as key modifiers of treatment efficacy. Conclusions: Liver resection provides superior local tumor control, whereas overall survival remains largely comparable between modalities in carefully selected patients. Treatment selection should be individualized, integrating tumor characteristics, liver function, patient comorbidities, and procedural risk within a multidisciplinary framework.Keywords
This publication has 19 references indexed in Scilit:
- Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3–5 cm hepatocellular carcinomaLangenbeck's Archives of Surgery, 2025
- Treatment strategies for solitary hepatocellular carcinoma: comparative outcomes of radiofrequency ablation vs. laparoscopic liver resection based on tumor locationSurgical Endoscopy, 2025
- Laparoscopic liver resection versus radiofrequency ablation for small hepatocellular carcinoma: randomized clinical trialBritish Journal of Surgery, 2024
- Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studiesHepatology International, 2024
- Comparison of Surgical Resection and Radiofrequency Ablation in Elderly Patients with Hepatocellular CarcinomaDigestive Diseases and Sciences, 2024
- Liver resection versus radiofrequency ablation or trans-arterial chemoembolization for early-stage (BCLC A) oligo-nodular hepatocellular carcinoma: meta-analysisBJS Open, 2024
- Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center studyThe American Journal of Surgery, 2020
- Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer DatabaseEuropean Radiology, 2018
- Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinomaBritish Journal of Surgery, 2017
- Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinomaJournal of Hepatology, 2013